Reinsurers' record returns are about to meet 25% price cuts

Fitch Ratings, in an analysis reported by Reinsurance News, puts the first-half 2026 return on equity for Europe's four largest reinsurers at a record 21.5%. The agency warns that consecutive cuts to renewal prices will feed into earnings over the coming quarters.

The revenue accounts have already turned. Combined revenue for the big four fell 2.7% in the first half. That quickened from a 1.1% decline a year earlier. Property and casualty led the drop, with revenue down 9.4%. Life and health revenue rose 3.8%.

Fitch attributes the divergence to a deliberate strategy at Munich Re, Swiss Re, Hannover Re and SCOR: take less business at renewals rather than chase growth. The agency still expects the four to meet ambitious full-year 2026 profit targets even as revenue declines for most.

Fitch points to the usual cushions: disciplined cycle management, diversified books, and stronger prior-year reserve releases. Those should support earnings as market conditions soften and claims costs rise.

The renewal numbers are blunt. Risk-adjusted prices fell by mid-teens at the January renewals. By April, the drop had widened to high teens. At mid-year, Fitch put the decline at 20% to 25%, with nat cat lines hit hardest. Specialty softened on surplus capacity; casualty held broadly stable.

The big four insist renewal prices still reflect the risks, and they have kept terms and attachment points largely unchanged through 2026. That speaks to the quality of current pricing. The earnings impact is a matter of timing.

Reinsurance earnings lag the market. A contract signed at mid-year 2026 carries a price as much as 25% below last year's level, but the premium is earned over time. The record first half came mostly from older contracts, helped by benign large losses and strong investment returns.

Why keep cutting? The supply side. AM Best expects reinsurance capital to hit a record $705 billion in 2026 even as risk budgets shrink, as ICD has reported. More capital chasing less risk is the classic softening-market setup, and Fitch's renewal numbers are the proof.

The same softness shows up in insurance-linked securities. Cat bond sponsors have been testing cascading structures and third-event tranches while first-quarter spreads held firm, as ICD noted earlier. Now the mid-year renewals put a number on it: nat cat lines are down 20% to 25%, and the collateralized market prices off that level. Spreads can hold even as the underlying price of risk falls. That gap is where this cycle will be decided.

The big four's tactic is to hold terms, let prices fall, and walk away from accounts that don't pay. That pushes marginal volume toward the rest of the market. Third-party capital in collateralized reinsurance and sidecars could write more of that risk, but lower prices test appetite rather than guarantee transfer.

The next earnings season will test the gap between what reinsurers say and what their income statements show. If they hold full-year targets as revenue declines, the 21.5% return reads as peak-cycle. If price cuts outrun reserve releases, the softening shows in returns well before it shows in pricing. Fitch calls the interim 'pronounced.' The direction is not in dispute.